Does RIVAROXABAN Cause Product prescribing issue? 359 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 359 reports of Product prescribing issue have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.3% of all adverse event reports for RIVAROXABAN.
359
Reports of Product prescribing issue with RIVAROXABAN
0.3%
of all RIVAROXABAN reports
12
Deaths
187
Hospitalizations
How Dangerous Is Product prescribing issue From RIVAROXABAN?
Of the 359 reports, 12 (3.3%) resulted in death, 187 (52.1%) required hospitalization, and 29 (8.1%) were considered life-threatening.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 359 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
MORPHINE (288)
Which RIVAROXABAN Alternatives Have Lower Product prescribing issue Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM